Search results
Advancements in Biologic Therapies for Psoriatic Arthritis
Medscape· 6 days agoThe latest developments in biological therapies for psoriatic arthritis (PsA) are reviewed by Dr...
Low stress resilience is linked to increased risk of psoriasis
Medical Xpress· 5 days agoAs part of the enlistment process, all the men underwent psychological assessment in accordance with...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 5 days agoTakeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...
What To Know and Do About Jaw Pain on One Side
Health via Yahoo News· 11 hours agoCancer: Oral cancer can cause one-sided jaw pain, difficulty moving your mouth, and swelling in your jaw. Arthritis: Some forms of arthritis, including...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 6 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said ...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 5 days ago-inhibiting monoclonal antibody. It was first approved as a treatment for moderate to severe plaque...
Inflammaging Could Be the Cause of Your Fatigue — How One Woman Finally Found Relief
The Sacramento Bee· 2 hours agoWhile sleep might not be the fix, there is a diet change that can help. It worked for Jane Wooten. The 68-year-old fought fatigue, pain, GI issues and more until she discovered the solution that restored her health.
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 5 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS
ETF DAILY NEWS· 3 days agoAlvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...
Summit X LLC Reduces Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoSummit X LLC lessened its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC ...
